Indonesia lauds ACF-A's role in developing COVID-19 vaccines

Printer-friendly versionPrinter-friendly version
Send to friend: 
President Joko Widodo speech on ACT-Accelerator Campaign 2022 on Wednesday (Feb 9, 2022). ANTARA/Rangga Pandu Asmara Jingga

Jakarta, February 10 (ANTARA) - Indonesian President Joko Widodo has lauded the role played by the Access to COVID-19 Tools Accelerator (ACT-A) in encouraging the development of COVID-19 drugs, tools, and vaccines.
"Thank you the WHO (World Health Organization) director general for your invitation. I highly appreciate ACT-A's role in encouraging the development of and fair access to COVID-19 drugs, diagnosis devices, and vaccines," he remarked in a virtual address at the ACT-Accelerator Campaign 2022, accessed through the Youtube channel of the Presidential Secretariat on Wednesday evening (Feb 9).
ACT-A is an essential part of the global health architecture and concrete proof of the benefits of multilateralism, he said.
Looking ahead, ACT-A's role will still be badly needed, particularly to bridge global vaccine inequality, Widodo added.
"No one is safe until everyone is. I call on countries and donors to use this opportunity to strengthen their support for ACT-A," he said.
During its G20 Presidency, Indonesia will strengthen global health architecture as one of its priority agendas, he added.